Neoprobe News

An investigation on behalf of current long-term stockholders of shares of Navidea Biopharmaceuticals Inc was announced concerning whether certain Navidea Biopharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements.

The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats.

Navidea Biopharmaceuticals Announces Presentation of Meta-Analysis Results of LymphoseekA and ACOSOG Radiolabeled Colloid in Head and Neck Cancer Staying up-to-date has never been simpler.

Navidea Biopharmaceuticals Announces Presentation of Results from Two Lymphoseek A and Radiolabeled Colloid Studies in Lymphatic Mapping for Breast Cancer at SNMMI )--Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced results from two separate studies that compared ... (more)

Navidea Biopharmaceuticals Announces Data Presentations at 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging Staying up-to-date has never been simpler.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Thomas Tulip, President and Chief Business Officer, will participate at the Jefferies 2013 Global Healthcare Conference on June 3-6, 2013 at the Grand Hyatt in New York City, NY.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Navidea Biopharmaceuticals, Inc.